...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Enthusiasm? NOT!

Probably the poorest presentation as far as passion and excitement I've ever heard from him...(how do all these rumors ever start about "eminent sale or partnership")

Someday we'll get some interest in monetizing this puppy? Hopefully in this decade!

Share
New Message
Please login to post a reply